CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice

Area of Science:

• Oncology
• Molecular Biology
• Dermatology

Background:

• Mutations in the tumor suppressor p53 gene occur in over 50% of human cancers.
• Mutant p53 loses its ability to activate genes crucial for DNA repair and apoptosis.
• Chronic UVB exposure is a known cause of skin cancer and can induce p53 mutations.

Purpose of the Study:

• To investigate the in vivo effectiveness of CP-31398, a compound that restores tumor suppressor functions of mutant p53.
• To determine if CP-31398 can block UVB-induced skin carcinogenesis.
• To elucidate the molecular mechanisms underlying CP-31398's action in skin cancer.

Main Methods:

• Treatment of UVB-irradiated mice and human skin carcinoma cells with CP-31398.
• Analysis of p53, p21, BclXs, Bcl2, proliferating cell nuclear antigen, and cyclin D1 expression.
• Assessment of caspase-3 activation, poly (ADP-ribose) polymerase cleavage, and apoptosis.
• Investigation of p53 mitochondrial translocation and mitochondrial membrane permeability transition (MPT).

Main Results:

• CP-31398 significantly blocked UVB-induced skin carcinogenesis in mice.
• The compound increased levels of p53, p21, and BclXs while downregulating Bcl2, PCNA, and cyclin D1.
• CP-31398 induced apoptosis via p53-dependent pathways, including mitochondrial translocation and cytochrome c release.
• Similar pro-apoptotic effects were observed in human skin carcinoma cells with mutant p53.

Conclusions:

• CP-31398 effectively restores p53 tumor suppressor functions in vivo, blocking UVB-induced skin carcinogenesis.
• The compound's mechanism involves p53-dependent apoptosis induction through mitochondrial pathways.
• Small molecule compounds that reconstitute p53 function hold promise for preventing and treating skin cancer.